Status: Recruiting
The Effect of Echinacea (Immulant ®) in the Treatment of CRYPTOSPORIDIOSIS in Immunocompromised Children
This study aims to: 1. To evaluate the effectiveness of Immulant ® addition to standard treatment in reducing clinical symptoms of Cryptosporidiosis in immunocompromised children. 2. To measure the changes in parasite count in stool samples after treatment with Immulant ®. 3. To assess the safety and tolerability of Immulant ® in children participating in the study.
Participants needed: 60
Trial details
Phase: Phase 2Age: 5-12Biological sex: AllType: InterventionalSponsor: Al-Azhar UniversityUpdated: Feb 5, 2026Locations: 1
Eligibility criteria
Clinical diagnosis of Cryptosporidiosis Disease [+3]
Patients undergoing organ transplantation [+2]